ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

January 22, 1988

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

Guest Commentary by Richard Rettig: Kennedy’s War On Cancer Began With National Cancer Act Of 1971.

May 23, 2008

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

July 11, 2014